Cefoperazone sodium structure
|
Common Name | Cefoperazone sodium | ||
---|---|---|---|---|
CAS Number | 62893-20-3 | Molecular Weight | 667.649 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C25H26N9NaO8S2 | Melting Point | 200-202°C | |
MSDS | Chinese USA | Flash Point | N/A | |
Symbol |
GHS08 |
Signal Word | Danger |
Use of Cefoperazone sodiumCefoperazone sodium salt is a cephalosporin antibiotic for inhibition of rMrp2-mediated [3H]E217βG uptake with IC50 of 199 μM.Target: AntibacterialCefoperazone is a sterile, semisynthetic, broad-spectrum, parenteral cephalosporin antibiotic for intravenous or intramuscular administration. After intravenous administration of 2 g of Cefoperazone, levels in serum rang from 202μg/mL to 375 μg/mL depending on the period of drug administration. After intramuscular injection of 2 g of Cefoperazone, the mean peak serum level is 111 μg/mL at 1.5 hours. At 12 hours after dosing, mean serum levels are still 2 to 4 μg/mL. Cefoperazone is 90% bound to serum proteins. |
Name | sodium,(6R,7R)-7-[[(2R)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |
---|---|
Synonym | More Synonyms |
Description | Cefoperazone sodium salt is a cephalosporin antibiotic for inhibition of rMrp2-mediated [3H]E217βG uptake with IC50 of 199 μM.Target: AntibacterialCefoperazone is a sterile, semisynthetic, broad-spectrum, parenteral cephalosporin antibiotic for intravenous or intramuscular administration. After intravenous administration of 2 g of Cefoperazone, levels in serum rang from 202μg/mL to 375 μg/mL depending on the period of drug administration. After intramuscular injection of 2 g of Cefoperazone, the mean peak serum level is 111 μg/mL at 1.5 hours. At 12 hours after dosing, mean serum levels are still 2 to 4 μg/mL. Cefoperazone is 90% bound to serum proteins. |
---|---|
Related Catalog | |
References |
Melting Point | 200-202°C |
---|---|
Molecular Formula | C25H26N9NaO8S2 |
Molecular Weight | 667.649 |
Exact Mass | 667.124329 |
PSA | 273.69000 |
Water Solubility | H2O: 50 mg/mL, clear, faintly yellow |
Symbol |
GHS08 |
---|---|
Signal Word | Danger |
Hazard Statements | H317-H334 |
Precautionary Statements | P261-P280-P342 + P311 |
Hazard Codes | Xn:Harmful |
Risk Phrases | R42/43 |
Safety Phrases | S22-S36/37 |
RIDADR | NONH for all modes of transport |
WGK Germany | 2 |
RTECS | XI0374000 |
HS Code | 2941905600 |
~97% Cefoperazone sodium CAS#:62893-20-3 |
Literature: DSM SINOCHEM PHARMACEUTICALS NETHERLANDS B.V.; MAO, Chang-Long; XU, Jian-Jun; SONG, Bo Patent: WO2014/12849 A1, 2014 ; Location in patent: Page/Page column 6; 7 ; |
Precursor 1 | |
---|---|
DownStream 0 |
HS Code | 2941905600 |
---|
Housing conditions modulate the severity of Mycoplasma pulmonis infection in mice deficient in class A scavenger receptor.
Comp. Med. 64(6) , 424-39, (2014) Mycoplasmosis is a frequent causative microbial agent of community-acquired pneumonia and has been linked to exacerbation of chronic obstructive pulmonary disease. The macrophage class A scavenger rec... |
|
Randomized comparison of piperacillin-tazobactam plus amikacin versus cefoperazone-sulbactam plus amikacin for management of febrile neutropenia in children with lymphoma and solid tumors.
Pediatr. Hematol. Oncol. 30(2) , 141-8, (2013) The objective of this study was to compare the effectiveness of piperacillin-tazobactam (PIP/TAZO) plus amikacin (AMK) (PIP/TAZO+AMK) versus cefoperazone-sulbactam (CS) plus AMK (CS+AMK) for the treat... |
|
Interaction between caspofungin or voriconazole and cefoperazone-sulbactam or piperacillin-tazobactam by in vitro and in vivo methods.
APMIS 122(5) , 412-7, (2014) Immunosuppressive patients are at risk of fungal and bacterial infections. Therefore, these patients receive prophylactic, preemptive, empirical or target antifungal and concomitant antibiotic therapy... |
Cefoperazone sodium |
MFCD07793331 |
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2R)-2-[[(4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl]amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-, sodium salt, (6R,7R)- (1:1) |
Sodium (6R,7R)-7-{[(2R)-2-{[(4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl]amino}-2-(4-hydroxyphenyl)acetyl]amino}-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |
Sodium (6R,7R)-7-{[(2R)-2-{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}-2-(4-hydroxyphenyl)acetyl]amino}-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |
cefoperazone-Na |
Natrium-(6R,7R)-7-{[(2R)-2-{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}-2-(4-hydroxyphenyl)acetyl]amino}-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-2-carboxylat |
Sodium cefoperazone |
cefoperazone monosodium |
EINECS 263-751-5 |
Tomabef |
cephoperazone sodium |
Cefoperazone sodium [USAN:JAN] |
Cefoperazone sodium salt |
CEFOBID IN PLASTIC CONTAINER |
T 1551 |
Cefoperazone sodium (JP15/USP) |
Cefoperazonesodium |
Cefoperazone (sodium salt) |